Related Experiment Video
Updated: May 27, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
Metastatic bladder cancer: a review of current management
Andrew Fletcher1, Ananya Choudhury, Nooreen Alam
1Department of Palliative and Supportive Care, The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.
Abstract:
Bladder cancer continues to result in substantial morbidity and mortality for affected individuals. Advances in the management of metastatic bladder cancer have been limited. Chemotherapy with platinum-based regimes remains the mainstay of first-line treatment. Studies investigating alternative regimes have offered no survival advantage. Targeted therapies may offer benefit either as single agent or in combination with chemotherapy. Symptoms due to metastatic bladder cancer impact patients' quality of life, and therefore holistic management is vital. Such management includes radiotherapy, bisphosphonates, and the involvement of specialist palliative care services. This review will discuss the current management for metastatic bladder cancer, future potential treatment modalities, and the evidence to support the management strategies.
Insights
Metastatic bladder cancer management is challenging, with platinum-based chemotherapy as the primary treatment. Future strategies may involve targeted therapies and holistic care to improve patient quality of life.
Area of Science:
- Oncology
- Urology
Background:
- Bladder cancer significantly impacts patient morbidity and mortality.
- Current advances in metastatic bladder cancer management are limited.
- Platinum-based chemotherapy is the standard first-line treatment.
Purpose of the Study:
- To review current management strategies for metastatic bladder cancer.
- To explore potential future treatment modalities.
- To discuss the evidence supporting these management approaches.
Main Methods:
- Literature review of current and emerging treatments for metastatic bladder cancer.
- Analysis of evidence for chemotherapy, targeted therapies, and supportive care.
- Discussion of holistic management including radiotherapy and palliative care.
Main Results:
- Limited survival advantage from alternative chemotherapy regimens.
- Potential benefit of targeted therapies as single agents or in combination.
- Importance of holistic management including radiotherapy and palliative care.
Conclusions:
- Metastatic bladder cancer treatment remains challenging.
- Targeted therapies represent a promising avenue for future treatment.
- Comprehensive, holistic care is vital for improving patient quality of life.
Related Concept Videos
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi V: Nursing Management
Urinary Tract Calculi VI: Surgical Management
Urinary Tract Infection IV: Nursing Management
